U.S. flag

An official website of the United States government

NM_000551.4(VHL):c.277G>C (p.Gly93Arg) AND multiple conditions

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Mar 11, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001035237.4

Allele description [Variation Report for NM_000551.4(VHL):c.277G>C (p.Gly93Arg)]

NM_000551.4(VHL):c.277G>C (p.Gly93Arg)

Gene:
VHL:von Hippel-Lindau tumor suppressor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_000551.4(VHL):c.277G>C (p.Gly93Arg)
HGVS:
  • NC_000003.12:g.10142124G>C
  • NG_008212.3:g.5490G>C
  • NM_000551.4:c.277G>CMANE SELECT
  • NM_001354723.2:c.277G>C
  • NM_198156.3:c.277G>C
  • NP_000542.1:p.Gly93Arg
  • NP_000542.1:p.Gly93Arg
  • NP_001341652.1:p.Gly93Arg
  • NP_937799.1:p.Gly93Arg
  • LRG_322t1:c.277G>C
  • LRG_322:g.5490G>C
  • LRG_322p1:p.Gly93Arg
  • NC_000003.11:g.10183808G>C
  • NM_000551.3:c.277G>C
  • p.[Gly93Arg]
Protein change:
G93R
Links:
dbSNP: rs5030808
NCBI 1000 Genomes Browser:
rs5030808
Molecular consequence:
  • NM_000551.4:c.277G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354723.2:c.277G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198156.3:c.277G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Chuvash polycythemia
Synonyms:
POLYCYTHEMIA, VHL-DEPENDENT; Erythrocytosis, familial, 2
Identifiers:
MONDO: MONDO:0009892; MedGen: C1837915; Orphanet: 238557; OMIM: 263400
Name:
Von Hippel-Lindau syndrome (VHLS)
Synonyms:
VHL syndrome; Von Hippel-Lindau
Identifiers:
MONDO: MONDO:0008667; MedGen: C0019562; Orphanet: 892; OMIM: 193300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001198557Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Mar 11, 2022)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe.

Glavac D, Neumann HP, Wittke C, Jaenig H, Masek O, Streicher T, Pausch F, Engelhardt D, Plate KH, Höfler H, Chen F, Zbar B, Brauch H.

Hum Genet. 1996 Sep;98(3):271-80.

PubMed [citation]
PMID:
8707293

Functioning thoracic paraganglioma: association with Von Hippel-Lindau syndrome.

Bender BU, Altehöfer C, Januszewicz A, Gärtner R, Schmidt H, Hoffmann MM, Heidemann PH, Neumann HP.

J Clin Endocrinol Metab. 1997 Oct;82(10):3356-60.

PubMed [citation]
PMID:
9329368
See all PubMed Citations (8)

Details of each submission

From Invitae, SCV001198557.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly93 amino acid residue in VHL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8707293, 9329368, 12000816, 17661816, 17922902). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VHL protein function. ClinVar contains an entry for this variant (Variation ID: 223174). This variant is also known as 490G>C (p.Gly93Arg). This missense change has been observed in individual(s) with VHL-related conditions (PMID: 20660572, 23660872; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 93 of the VHL protein (p.Gly93Arg).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024